These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex. Fuentes-Prior P; Iwanaga Y; Huber R; Pagila R; Rumennik G; Seto M; Morser J; Light DR; Bode W Nature; 2000 Mar; 404(6777):518-25. PubMed ID: 10761923 [TBL] [Abstract][Full Text] [Related]
5. Structure and interaction modes of thrombin. Bode W Blood Cells Mol Dis; 2006; 36(2):122-30. PubMed ID: 16480903 [TBL] [Abstract][Full Text] [Related]
6. Thrombin structure and function: why thrombin is the primary target for antithrombotics. Fenton JW; Ofosu FA; Moon DG; Maraganore JM Blood Coagul Fibrinolysis; 1991 Feb; 2(1):69-75. PubMed ID: 1772999 [TBL] [Abstract][Full Text] [Related]
7. Cellular effects of thrombin: pharmacology of the receptor(s) in various cell types and possible development of receptor antagonists. De Caterina R; Sicari R Pharmacol Res; 1993; 27(1):1-19. PubMed ID: 8384364 [TBL] [Abstract][Full Text] [Related]
9. A player of many parts: the spotlight falls on thrombin's structure. Stubbs MT; Bode W Thromb Res; 1993 Jan; 69(1):1-58. PubMed ID: 8465268 [TBL] [Abstract][Full Text] [Related]
10. Thrombin, thrombin inhibitors, and the arterial thrombotic process. Maraganore JM Thromb Haemost; 1993 Jul; 70(1):208-11. PubMed ID: 8236106 [No Abstract] [Full Text] [Related]
11. An overview of the structure and function of thrombin. Davie EW; Kulman JD Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():3-15. PubMed ID: 16673262 [TBL] [Abstract][Full Text] [Related]
12. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches. Bhunia SS; Roy KK; Saxena AK J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917 [TBL] [Abstract][Full Text] [Related]
13. New direction for WE thrombin. Berndt MC; Andrews RK Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):205-7. PubMed ID: 18216328 [No Abstract] [Full Text] [Related]
15. [Thrombosis and thrombin]. Hemker HC; Béguin S Ann Pharm Fr; 1992; 50(3):121-35. PubMed ID: 1290382 [TBL] [Abstract][Full Text] [Related]
16. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships. Bode W; Turk D; Karshikov A Protein Sci; 1992 Apr; 1(4):426-71. PubMed ID: 1304349 [TBL] [Abstract][Full Text] [Related]
17. The Na+ binding channel of human coagulation proteases: novel insights on the structure and allosteric modulation revealed by molecular surface analysis. Silva FP; Antunes OA; de Alencastro RB; De Simone SG Biophys Chem; 2006 Feb; 119(3):282-94. PubMed ID: 16288954 [TBL] [Abstract][Full Text] [Related]
18. Fibrin, γ'-fibrinogen, and transclot pressure gradient control hemostatic clot growth during human blood flow over a collagen/tissue factor wound. Muthard RW; Welsh JD; Brass LF; Diamond SL Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):645-54. PubMed ID: 25614284 [TBL] [Abstract][Full Text] [Related]
20. [Overwiew of the Coagulation System and laboratory tests for its study]. Guerrero B; López M Invest Clin; 2015 Dec; 56(4):432-54. PubMed ID: 29938976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]